This is a letter regarding a recently published article in Breast Cancer Research by Tamimi et al (Breast Cancer Res 2008, 10(4):R67). Concerns regarding categorization of breast cancer molecular classes using surrogate immunohistochemical markers are discussed.
No takes yet. Share an insight, caveat, or question.
Bhargava et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: